Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model.
about
Antigen-specific immunotherapy of cervical and ovarian cancerAdoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.Perspectives for preventive and therapeutic HPV vaccines.Immunotherapy for cervical cancer: Research status and clinical potentialCombined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responses.Therapeutic Vaccine Strategies against Human Papillomavirus.The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.DNA vaccines, electroporation and their applications in cancer treatmentHuman papillomavirus vaccines for the treatment of cervical cancer.DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies.DNA vaccination and gene therapy: optimization and delivery for cancer therapy.Codon optimization of the rabbit hemorrhagic disease virus (RHDV) capsid gene leads to increased gene expression in Spodoptera frugiperda 9 (Sf9) cells.DNA vaccines for the treatment of prostate cancer.DNA vaccines for targeting bacterial infections.Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses.Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.Imaging of intracellular acidic compartments with a sensitive rhodamine based fluorogenic pH sensor.Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression.Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells.Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.Therapeutic human papillomavirus vaccines: current clinical trials and future directions
P2860
Q27488697-4A0C0F5F-02CB-4E28-BFC4-B78AC24656D9Q33713511-E8B0182A-EC15-4E4D-B147-8B5CD836F861Q33778143-FDC8DB6E-F691-49CB-B4D9-5A5B0ED28A24Q34011494-C796560C-6739-483D-9D56-1BDB251769C0Q34033763-BEC4BE28-AE6E-47AB-9501-D6F8EE20A085Q35082617-FF85F571-AFC7-4EE3-80B5-FF196363BF50Q35826752-A59A35E9-04A6-47CA-AF60-43DB44C011A9Q35867988-79279211-66AB-4066-8278-120A80003E69Q36256459-8DEAD477-EAA1-432A-83F6-8AB74A10BD92Q36690278-E59262FF-DB4B-4675-BDB1-FAC4D04D91D2Q37010987-7C4E5C1B-29D4-42EC-9580-4556C7D278F7Q37259636-F2D88172-2930-4815-8862-180A818ADDAAQ37453361-ACFD4DEB-E1D3-45C7-BC5E-7DA1F662FAC1Q37771942-74B83C35-A903-4434-B50F-D6D37DEFFC08Q37771943-BA7FE999-53E4-4374-B1D7-37990062C78DQ39181825-6B7C49E8-38E3-46E0-A1B8-BA2FCB6394B8Q39320921-375B4696-359C-4404-AC62-D49CC2D2DD0FQ39500384-857CDE1E-CA95-41B3-9603-BAF8508CA515Q39796159-1A9EB4DE-4E46-456E-B5F4-8484D25F63C8Q50222492-3138AEBC-1C14-4CB0-A3A4-51D635440533Q52691583-F4D08DA7-2C66-401F-8337-AB2DA4B3BEFAQ56937332-4D527EE7-EA6B-4B3B-A18D-4828B075C025
P2860
Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model.
description
2005 nî lūn-bûn
@nan
2005 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Both antigen optimization and ...... xpressing animal tumour model.
@en
Both antigen optimization and ...... xpressing animal tumour model.
@nl
type
label
Both antigen optimization and ...... xpressing animal tumour model.
@en
Both antigen optimization and ...... xpressing animal tumour model.
@nl
prefLabel
Both antigen optimization and ...... xpressing animal tumour model.
@en
Both antigen optimization and ...... xpressing animal tumour model.
@nl
P2860
P1433
P1476
Both antigen optimization and ...... xpressing animal tumour model.
@en
P2093
Jeong-Im Sin
Mi Suk Kim
P2860
P304
P356
10.1111/J.1365-2567.2005.02219.X
P577
2005-10-01T00:00:00Z